• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

盐酸地芬诺酯治疗小儿腹泻(作者译)

[Treatment of diarrhea with difenoxin hydrochloride in children (author's transl)].

作者信息

Pece H

出版信息

Arzneimittelforschung. 1979;29(5):849-51.

PMID:582988
Abstract

In an open clinical study symptomatic treatment was given to 93 children aged 16 days to 24 months who suffered from acute diarrhea. All the patients received antidiarrheal diet suited to their age. If indicated, the children were rehydrated with electrolyte and buffer solutions. In order to reduce the intestinal motility as well as the loss of water and electrolyte in the stool, but not to stop the stools, difenoxin hydrochloride (Lyspafen) in the commercial composition was prescribed. The dose was 1 drop/kg body weight/day administered in 3 single doses. The preparation was administered to the children for 4-6 days on the average. Regardless of the bacteriological findings in the stools, very good results were obtained in 59 patients (63.44%); sufficient results in 19 children (20.43%); and poor results in 15 children (16.13%). In the group with negative stool samples very good results were obtained in 74% of the patients. The therapeutic results were very good to sufficient in the majority of cases belonging to the group with facultative pathogenic germs and pathogenic coli in the stools. In 66.67% (4 cases) of the children infected by Salmonellae and Shigellae the treatment was insufficient. No undesirable adverse reactions were seen in the children treated. Summing-up of the results revealed that cure of or improvement in the diarrhea was obtained in 83.87% of the test population.

摘要

在一项开放性临床研究中,对93名年龄在16天至24个月之间患有急性腹泻的儿童进行了对症治疗。所有患者均接受适合其年龄的止泻饮食。如有必要,用电解质和缓冲溶液对儿童进行补液。为了减少肠道蠕动以及粪便中的水分和电解质流失,但又不阻止排便,开了市售复方的盐酸地芬诺酯(利舒芬)。剂量为1滴/千克体重/天,分3次单剂量给药。该制剂平均给儿童服用4至6天。无论粪便的细菌学检查结果如何,59例患者(63.44%)取得了非常好的效果;19名儿童(20.43%)取得了足够的效果;15名儿童(16.13%)效果不佳。在粪便样本阴性的组中,74%的患者取得了非常好的效果。在粪便中含有兼性病原菌和致病性大肠杆菌的大多数病例组中,治疗效果非常好至足够。在感染沙门氏菌和志贺氏菌的儿童中,66.67%(4例)的治疗效果不佳。在接受治疗的儿童中未观察到不良不良反应。结果总结显示,83.87%的受试人群腹泻得到治愈或改善。

相似文献

1
[Treatment of diarrhea with difenoxin hydrochloride in children (author's transl)].盐酸地芬诺酯治疗小儿腹泻(作者译)
Arzneimittelforschung. 1979;29(5):849-51.
2
[Special consideration of clinical and travelling medical criteria (author's transl)].临床及旅行医学标准的特殊考量(作者译)
Arzneimittelforschung. 1979;29(4):685-8.
3
[Difenoxin hydrochloride; a new antidiarrheal agent; preliminary results of cases of chronic diarrhoea (author's transl)].
Schweiz Rundsch Med Prax. 1976 Jan 20;65(3):84-6.
4
[Diphenoxinhydrochloride, a new anti-diarrhea agent].
Schweiz Med Wochenschr. 1976 Nov 20;106(47):1650-3.
5
[Clinical evaluation of the anti-diarrheal activity of C-C2484 (Difenoxin) in pediatrics, in a controlled of patients].[C-C2484(地芬诺辛)在儿科患者中的止泻活性对照临床评估]
Minerva Pediatr. 1980 Dec 31;32(24):1399-404.
6
Evaluation of efficacy and safety of lomotil in acute diarrhoeas in children.洛哌丁胺治疗儿童急性腹泻的疗效与安全性评估。
Indian Pediatr. 1979 Oct;16(10):903-7.
7
Safety of diphenoxylate hydrochloride therapy in malnourished infants suffering with nonspecific diarrhoea.盐酸地芬诺酯治疗营养不良伴非特异性腹泻婴儿的安全性。
Indian Pediatr. 1979 Oct;16(10):909-12.
8
[Lyspafen and acute diarrhoe in pediatry (author's transl)].[赖氨酸匹林与儿科急性腹泻(作者译)]
Ther Umsch. 1979 Sep;36(9):836-40.
9
[Double-blind study of difenoxin hydrochloride among travellers to tropical countries (author's transl)].盐酸地芬诺酯在前往热带国家旅行者中的双盲研究(作者译)
Ther Umsch. 1979 Mar;36(3):267-70.
10
Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.大肠杆菌O157:H7感染期间的相对肾脏保护作用:与静脉补液扩容的关系
Pediatrics. 2005 Jun;115(6):e673-80. doi: 10.1542/peds.2004-2236.